Records containing: Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-22A Phase 3 Trial of Fianlimab (REGN3767, Anti-LAG-3) + Cemiplimab Versus Pembrolizumab in Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2026-04-21A Phase 1/2 Randomized, Blinded, Placebo Controlled Study of Ipilimumab in Combination With Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2026-04-20Open Label, Multi-center Roll-over Study to Assess Long Term Safety in Patients Who Have Completed a Global Novartis or GSK Sponsored Dabrafenib and/or Trametinib Study
-
CLINICAL_TRIALS study record update · 2026-04-20An Open Label Phase I PET Imaging Study to Investigate the Bio-distribution and Tumor Uptake of [89Zr]Zr-BI 765063 and [89Zr]Zr-BI 770371 in Patients With Head and Neck Squamous Cell Carcinoma, Non-small Cell Lung Cancer or Melanoma Who Are Treated With Ezabenlimab
-
CLINICAL_TRIALS study record update · 2026-04-20Follow-Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-20A Phase I, Open Label Single-arm Two-part Study to Investigate Safety, Pharmacokinetics, and Preliminary Efficacy of Pan-RAF/MEK Glue NST-628 Oral Tablets in Subject With Solid Tumors Harboring Genetic Alterations in the MAPK Pathway and With Other Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-04-17A Phase 1, Open-Label, Multiple-Ascending Dose Study of the Safety and Tolerability of CTX-471 Administered Either as a Monotherapy or in Combination With Pembrolizumab in Patients With Inadequate Responses to PD-1/PD-L1 Checkpoint Inhibitors in Metastatic or Locally Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2026-04-16Phase IIa Study of HX009+IN10018 in Patients With Advanced Solid Tumours, Including Biliary Tract Malignancies and Malignant Melanoma, Treated With or Without Standard Chemotherapy
-
CLINICAL_TRIALS study record update · 2026-04-16Patient Preference for Subcutaneous vs. Intravenous Immune Therapy (PSI-Immune)
-
CLINICAL_TRIALS study record update · 2026-04-16An Open-label, Multi-center, Phase I, Dose Finding Study of Oral TNO155 in Adult Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-04-16Well-Being and Quality of Life in Melanoma Patients During COVID-19 Pandemic
-
CLINICAL_TRIALS study record update · 2026-04-16Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2026-04-15A First-in-human, Phase I, Open-label, Non-randomized, Multicentre Dose Escalation and Expansion Trial of BI 3810944 in Patients With Solid Tumours and Melanoma
-
CLINICAL_TRIALS study record update · 2026-04-15B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
-
CLINICAL_TRIALS study record update · 2026-04-15A Phase Ia/Ib, Open Label, Multicenter, Dose-escalation Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Patients With Locally Advanced or Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-04-15A Multicenter, Randomized, Double-Blind, Parallel-Controlled Phase I Clinical Study to Evaluate the Pharmacokinetic Profile, Efficacy, Safety and Immunogenicity of HLX18 vs. OPDIVO® (US-sourced OPDIVO®) in Multiple Resected Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-04-14Personalized Cancer Support for Young Adults
-
CLINICAL_TRIALS study record update · 2026-04-14Cell Harvest and Preparation for Surgery Branch Treatment Protocols
-
CLINICAL_TRIALS study record update · 2026-04-14TNF in Melanoma Patients Treated With Immunotherapy
-
CLINICAL_TRIALS study record update · 2026-04-13Phase I Pilot Study of RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis
-
CLINICAL_TRIALS study record update · 2026-04-13Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance
-
CLINICAL_TRIALS study record update · 2026-04-13Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)
-
CLINICAL_TRIALS study record update · 2026-04-13An Early Phase 1 Study of ABT-888 in Combination With Carboplatin and Paclitaxel in Patients With Hepatic or Renal Dysfunction and Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-04-13Treatment of Visceral Localizations With Electrochemotherapy in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype: Monocenter, Single Arm, Clinical Investigation
-
CLINICAL_TRIALS study record update · 2026-04-13Cancer Moonshot Biobank Research Protocol